Search This Blog

Thursday, March 6, 2025

"Vandalism Is Not Free Speech!" Elon Musk Speaks Out After Rise In Tesla Protests, Defacements

 The vandalism of Tesla vehicles as a backlash to Elon Musk's foray into politics has gotten so bad that vehicle owners are being forced to alter the appearance of their cars to try and distance themselves from Musk and the Tesla name.

The Daily News wrote that some owners are using stickers and logos from other brands or displaying messages like “Anti-Elon Tesla Club” to distance themselves from Musk.

Social media posts show altered Teslas resembling Audis, Mazdas, or Hondas, while an EV website reports a surge in sales of Musk-related decals. 

Additionally, there have been a number of reports of vandalism of Tesla property and protests outside of Tesla stores worldwide. 

For example, a woman suspected of attempted arson and repeated vandalism at a Northern Colorado Tesla dealership was arrested last Monday—the fourth such incident in recent weeks. Lucy Grace Nelson was taken into custody after allegedly returning with more incendiary devices and vandalism materials.

Prior incidents occurred on Jan. 29, Feb. 2, and Feb. 7, though details on the materials remain unknown, according to NBC

Molotov cocktails were allegedly thrown at vehicles, and “Nazi cars” was spray-painted on a Tesla dealership. Similar vandalism has occurred elsewhere, including a Cybertruck in California and a Tesla charger in Utah, both defaced with “Nazi” graffiti and swastikas, Yahoo! News added.

After a suspect in Brookline was found to be "tagging Tesla vehicles with Elon Musk decals" this week, Musk responded on X, stating: "Damaging the property of others, aka vandalism, is not free speech!"

US Justice Dept to ramp up staffing for immigration cases

  The U.S. Justice Department will focus on hiring prosecutors in offices near U.S. borders to enforce President Donald Trump's crackdown on illegal immigration, despite a federal hiring freeze, according to the new U.S. deputy attorney general.

The directive is designed to boost staffing for cases involving illegal entry into the United States, drug and human trafficking and activity by drug cartels, Deputy Attorney General Todd Blanche wrote in a memo to department staff on Thursday and seen by Reuters.

"Border Districts have a unique role to play in these efforts," Blanche wrote in the memo.

The exemption from the hiring freeze will apply to U.S. attorney's offices in Texas, Arizona, New Mexico and southern California along the U.S.-Mexico border. It will also apply to districts in Florida as well as in New York and Vermont near the Canadian border, where Blanche said illegal immigration had increased in recent years.

The move is the latest indication that the Justice Department under Trump plans to prioritize immigration-related crimes. Department officials have already directed prosecutors to scale back enforcement in areas such as foreign bribery and covert influence to focus on immigration issues.

Justice Department leadership has told prosecutors to bring the most serious charges available in cases related to immigration.

Blanche, a former top criminal defense lawyer for Trump, was confirmed by the Senate on Wednesday and sworn in as the department's second-highest ranking official on Thursday.

He urged lawyers at the Justice Department's Washington headquarters to voluntarily accept transfers to border districts and suggested some prosecutors would be required to go if there were not enough volunteers.

Federal prosecutors in those areas will seek to bring terrorism-related cases against certain cartels that Trump designated as foreign terrorist groups, Blanche wrote in the memo.

They will also pursue cases against local officials and advocacy groups accused of impeding federal immigration enforcement and harboring undocumented immigrants, according to the memo.

https://www.usnews.com/news/politics/articles/2025-03-06/us-justice-dept-to-ramp-up-staffing-for-immigration-cases

Bitcoin Slides After Trump Signs Strategic Reserve Executive Order

 After hinting at it to start the week, President Trump just signed an executive order on Thursday creating a Strategic Bitcoin Reserve, marking a major shift in U.S. digital asset policy.

White House Crypto and AI Czar David Sacks, a Silicon Valley venture capitalist, wrote in a post on X that the reserve will be funded exclusively with bitcoin seized in criminal and civil forfeiture cases, ensuring that taxpayers bear no financial burden... which helps explain why we are seeing selling-the-news pressure

Just a few minutes ago, President Trump signed an Executive Order to establish a Strategic Bitcoin Reserve.

The Reserve will be capitalized with Bitcoin owned by the federal government that was forfeited as part of criminal or civil asset forfeiture proceedings. 

This means it will not cost taxpayers a dime.

It is estimated that the U.S. government owns about 200,000 bitcoin; however, there has never been a complete audit. The E.O. directs a full accounting of the federal government’s digital asset holdings.

The U.S. will not sell any bitcoin deposited into the Reserve. It will be kept as a store of value.

The Reserve is like a digital Fort Knox for the cryptocurrency often called “digital gold.”

Premature sales of bitcoin have already cost U.S. taxpayers over $17 billion in lost value. 

Now the federal government will have a strategy to maximize the value of its holdings.

The Secretaries of Treasury and Commerce are authorized to develop budget-neutral strategies for acquiring additional bitcoin, provided that those strategies have no incremental costs on American taxpayers.

IN ADDITION, the Executive Order establishes a U.S. Digital Asset Stockpile, consisting of digital assets other than bitcoin forfeited in criminal or civil proceedings.

The government will not acquire additional assets for the Stockpile beyond those obtained through forfeiture proceedings.

The purpose of the Stockpile is responsible stewardship of the government’s digital assets under the Treasury Department.

PROMISES MADE, PROMISES KEPT

President Trump promised to create a Strategic Bitcoin Reserve and Digital Asset Stockpile. Those promises have been kept.

This Executive Order underscores President Trump’s commitment to making the U.S. the “crypto capital of the world.”

I want to thank the President for his leadership and vision in supporting this cutting-edge technology and for his rapid execution in supporting the digital asset industry. His administration is truly moving at “tech speed.”

I also want to thank the President’s Working Group on Digital Asset Markets — especially Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick — for their help and support in getting this done. Finally Bo Hines played a critical role as Executive Director of our Working Group.

Bitcoin is down around $3,000 on the news, holding above the levels seen before President Trump's posts on Sunday...

Steven Lubka, head of private clients and family offices at bitcoin-focused financial service firm Swan Bitcoin, said while having a stockpile could be a good first step, he eventually hopes to see a crypto reserve where the U.S. government would buy and accumulate bitcoin.

"They can hold onto seized assets and create a stockpile, but a stockpile is different from a strategic reserve, which would presumably involve purchasing assets and actively going into the markets to acquire or trade them," Ian Katz, analyst at policy research firm Capital Alpha Partners, told MarketWatch.

"The consensus on Capitol Hill is that it would require an act of Congress, and is unlikely to happen," Katz said.

A crypto stockpile is likely already priced in, Lubka said.

"The stockpile is good mostly on a signaling and a narrative basis, rather than [it being] really about the sales," Lubka said.

On the bright side, this order removes the constant overhang FUD that the US government will dump its holdings on the market at an inconvenient time, though "it would be good to have a congressional mandate over time to make the crypto stockpile or reserve protected from the next administration," Seth Ginns, head of liquid investments at crypto investment firm CoinFund told MarketWatch in a phone interview.

Whether the U.S. government holds or trades crypto, "that doesn't really matter, because it's more like a feather in the cap of legitimacy and use-case for this asset,Sue Ennis, head of investor relations at crypto-mining company Hut 8.

https://www.zerohedge.com/crypto/bitcoin-slides-after-trump-signs-strategic-reserve-executive-order

Arcturus Therapeutics Q4 2024 misses estimates

 Arcturus Therapeutics Holdings Inc. (ARCT) reported a wider-than-expected loss for the fourth quarter of 2024, with earnings per share (EPS) of -$1.11, missing the forecast of -$0.19. The company’s revenue also fell short of expectations, coming in at $22.8 million against the forecasted $63.22 million. Following the earnings release, Arcturus’ stock fell 6.95% in after-hours trading, with shares priced at $14.86, nearing its 52-week low of $14.30. According to InvestingPro data, the stock has experienced significant volatility, with a beta of 2.96, and has declined over 57% in the past year.

Key Takeaways

  • Arcturus reported a significant EPS miss, with a loss of $1.11 per share against a forecast of -$0.19.
  • Quarterly revenue decreased to $22.8 million, falling short of the expected $63.22 million.
  • The stock dropped 6.95% in after-hours trading, reflecting investor disappointment.
  • The company maintains a strong cash position with $293.9 million in cash and equivalents.
  • Key product developments include the approval of CoStave, a self-amplifying mRNA COVID-19 vaccine in the EU.

Company Performance

Arcturus Therapeutics experienced a challenging fourth quarter, with both revenue and earnings missing analyst expectations. The company’s annual revenue declined to $152.3 million, down $14.5 million from the previous year. Despite these setbacks, Arcturus continues to focus on its innovative self-amplifying mRNA platform, which it sees as a competitive advantage in the biotechnology sector. InvestingPro analysis indicates the stock is currently undervalued, with 7 additional exclusive ProTips available to subscribers. The company maintains a "GOOD" overall Financial Health score of 2.76, suggesting resilience despite current challenges.

Financial Highlights

  • Revenue: $22.8 million in Q4, down $8.1 million from the same quarter last year.
  • Annual Revenue: $152.3 million, a decrease of $14.5 million from 2023.
  • Net Loss: $30 million for Q4, translating to a loss of $1.11 per diluted share.
  • Cash and Equivalents: $293.9 million as of December 31, 2024, with InvestingPro data showing a strong current ratio of 4.76 and liquid assets exceeding short-term obligations. The company holds more cash than debt on its balance sheet, with total debt of just $29.42 million.

Earnings vs. Forecast

Arcturus reported an EPS of -$1.11, significantly below the forecasted -$0.19, resulting in a negative surprise. This miss is notable compared to previous quarters, where the company had managed to stay closer to analyst expectations. Revenue also fell short of the anticipated $63.22 million, coming in at $22.8 million.

Market Reaction

Following the earnings announcement, Arcturus’ stock declined by 6.95% in after-hours trading, with shares priced at $14.86. This drop positions the stock close to its 52-week low of $14.30, reflecting investor concerns over the company’s financial performance and future outlook.

Outlook & Guidance

Looking ahead, Arcturus has provided revised guidance for 2025, with projected EPS losses of -$0.3 for Q1 and -$0.09 for Q2. The company anticipates revenue of $62.5 million and $70.3 million for these quarters, respectively. Arcturus remains focused on expanding its therapeutic and vaccine pipelines, with interim data for key programs expected in 2025. 

https://www.investing.com/news/transcripts/earnings-call-transcript-arcturus-therapeutics-q4-2024-misses-estimates-93CH-3913762

Trump Floats Handing Off Student Loan Management to Treasury

 President Donald Trump said that the Treasury Department or other agencies could potentially take over administering student loans if his administration were to abolish the Education Department, which currently oversees the issue.

“That’ll be brought into either Treasury or Small Business Administration or Commerce. And we actually had that discussion today,” Trump told reporters Thursday in the Oval Office.

“I think it’ll be brought into Small Business maybe. Kelly really liked it,” Trump added referring to Kelly Loeffler, who heads the SBA.

Trump has said he plans to dismantle the Education Department, handing off its responsibilities to states and other federal agencies. His remarks come amid reports that he could soon sign a directive that would begin the process to close the agency, though he would likely need Congress’ approval to fully abolish it.

The Education Department holds broad responsibilities. In 2024, it distributed approximately $121 billion in federal grants, loans and work-study programs to nearly 10 million students, according to a report. An annual application, known as FAFSA, which it manages has also become a fixture in the college application process, used by universities to help determine eligibility for scholarships.

It also oversees a broad range of K-12 programs, including funding for low-income schools and students with disabilities.

Trump and his allies have assailed efforts by his predecessor, former President Joe Biden, to ease student debt burdens, including a sweeping loan forgiveness plan that was blocked by the courts. The Biden administration in the final days of his term offered more targeted relief for some borrowers.

https://finance.yahoo.com/news/trump-floats-handing-off-student-204349441.html

Cooper misses quarterly revenue estimates on lower-than-expected contact lens sales

 Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.6% year on year to $964.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.12 billion at the midpoint. Its non-GAAP profit of $0.92 per share was in line with analysts’ consensus estimates.


CooperCompanies (COO) Q4 CY2024 Highlights:

  • Revenue: $964.7 million vs analyst estimates of $980.4 million (3.6% year-on-year growth, 1.6% miss)

  • Adjusted EPS: $0.92 vs analyst estimates of $0.91 (in line)

  • The company reconfirmed its revenue guidance for the full year of $4.12 billion at the midpoint

  • Management slightly raised its full-year Adjusted EPS guidance to $3.98 at the midpoint

  • Operating Margin: 18.9%, up from 16.4% in the same quarter last year

  • Organic Revenue rose 6% year on year (7.5% in the same quarter last year)

  • Market Capitalization: $18.23 billion


Commenting on the results, Al White, Cooper's President and CEO said, "We started the year on a positive note meeting our revenue expectations and exceeding our operational targets. Moving forward, we remain confident in our ability to deliver strong growth and operational excellence, and this is reflected in our guidance."

https://finance.yahoo.com/news/coopercompanies-nasdaq-coo-misses-q4-212520550.html

Walgreens agrees to be acquired by Sycamore

 Total Consideration Consists of $11.45 per Share in Cash and Additional Potential Value of Up To $3.00 in Cash per WBA Share from Future Monetization of VillageMD Businesses

Sycamore and WBA Combine Retail and Healthcare Expertise to Better Position WBA to Accelerate Turnaround Plan

Walgreens Boots Alliance (NASDAQ: WBA) (the "Company" or "WBA") today announced that it has entered into a definitive agreement to be acquired by an entity affiliated with Sycamore Partners ("Sycamore"), a private equity firm specializing in retail, consumer and distribution-related investments. The total value of the transaction represents up to $23.7 billion


WBA shareholders will receive total consideration consisting of $11.45 per share in cash at closing of the Sycamore transaction (the "Cash Consideration") and one non-transferable right (a "Divested Asset Proceed Right" or "DAP Right") to receive up to $3.00 in cash per WBA share (together with the Cash Consideration, the "Total Consideration") from the future monetization of WBA’s debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses (such businesses, "Divested Assets"). The Cash Consideration represents a premium of 29%, and the Total Consideration represents a premium of up to 63%, to the WBA closing share price of $8.85 on December 9, 2024, the day prior to the first media reports regarding a potential transaction. Additional information about the future monetization of the Divested Assets and the DAP Rights is included below and a supplemental presentation can be found on the WBA investor relations website at investor.walgreensbootsalliance.com.

https://finance.yahoo.com/news/walgreens-boots-alliance-enters-definitive-221500923.html